Harvard Bioscience, Inc. - Common Stock - relatórios financeiros (NASDAQ:HBIO)

Harvard Bioscience, Inc. - Common Stock

Harvard Bioscience is a global developer, manufacturer and marketer of life sciences equipment to support research and drug discovery. It is traded on NASDAQ under the stock symbol HBIO. Headquartered in Holliston, Massachusetts, United States, the company's brands include: Biochrom, BTX, CMA, Data Sciences International, Harvard Apparatus, HEKA, Hugo Sachs Elektronik, KD Scientific, Multi Channel Systems, Panlab, and Warner Instruments. The company has approximately 355 employees, with 216 of those in the USA, and its principal manufacturing facilities are in New Brighton, Minnesota, Holliston, Massachusetts, Reutlingen, Germany, Barcelona, Spain, and March, Germany.

HBIO

Financials

Harvard Bioscience, Inc. - Common Stock

Notícias

Harvard Bioscience perde previsão de LPA no 1º tri de 2026 e ação cai

CFO da Harvard Bioscience compra US$ 25.000 em ações da HBIO

Diretor da Harvard Bioscience compra US$ 103.603 em ações da HBIO

Benchmark eleva preço-alvo da Harvard Bioscience para US$ 6 após desdobramento reverso

Benchmark raises Harvard Bioscience stock price target to $6 on reverse split

Benchmark reduz preço-alvo da Harvard Bioscience por preocupações com NIH

Benchmark cuts Harvard Bioscience stock price target on NIH concerns

Harvard Bioscience, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:HBIO) 2026-03-13

Harvard Bioscience apresenta margens em alta de 7 trimestres no Q4 2025

Harvard Bioscience Q4 2025 slides: margins hit 7-quarter high

Lucro da Harvard Bioscience veio abaixo das projeções por $0,10; receita supera estimativas

Harvard Bioscience earnings missed by $0.10, revenue topped estimates